ARCHIVES

Funding Opportunities: NCI’s RAPID Program; RFA, Pas Avilable

This article is from The Cancer Letter archive.

Vol. 25 No. 19 | May 14, 1999

Download PDF Visit The Full Archive

Related Articles

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

June 20, 2014

Pitt Inquiry Panel Proceedings Suspended, ORI To Take Over NSABP Investigation

July 22, 1994

Text of PDQ Statement on Breast Screening

September 17, 1993

NCCN in Transition: New Strategy to Examine Role of Informatics, Revenue Sources and International Programs

June 15, 2012

In Brief: Van Andel Institute to Build Epigenetics Hub

February 28, 2014

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

June 16, 1999